Neurodegenerative disorders present one of the most challenging fronts in modern medicine, with diseases like Alzheimer’s and Parkinson’s disease impacting ...

A webcast of each conference presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at https://investors.alector.com. Replays of the ...

The scientists found that HSV-1 activates transposable elements that impact the accumulation of Alzheimer's-linked proteins ...

Through this collaboration, Nanoscope Therapeutics will utilize Verana Health’s Qdata ® Retinitis Pigmentosa, which is a research-ready, real-world dataset that can be used to analyze patients with RP ...

The progressive loss of function and structure of neuronal cells is a process that falls under the name "neurodegeneration." Regardless of their etiology, ...

A new population-based study led by researchers from the Karolinska Institute in Sweden has found a common first-line class ...

Price-negotiation provisions that are out of step with reality are discouraging funders and Big Pharma partners from ...

The ‘NLRP3 inflammasome’ is like a control switch. In Alzheimer’s disease, its activation triggers an inflammatory response ...

Alzheimer’s disease remains one of the most pressing medical mysteries of our time. Despite decades of research, scientists are still uncovering the complex mechanisms behind this ... Continue Reading ...

Researchers from Cleveland Clinic's Genome Center have outlined the pathway human herpes simplex virus-1 (HSV1) can use to ...

AI tool uses MRI scans to track the pace of brain changes, mapping anatomic variations in regional brain aging rates according to factors including sex and age.

A new artificial intelligence model measures how fast a patient’s brain is aging and could be a powerful new tool for ...